Lifepsychol - two men play the guitar on chairs

Chroma, the UK’s leading national provider of arts therapy services, is to pilot Lifepsychol, an innovative new patient-driven system that could ultimately help up to 14 million people in the UK living with long-term or life-threatening conditions who wish to optimise their quality of life.

Giving users back control of their care, the easy-to-use web-based portal monitors real-time patient-self-reported quality of life indicators. Measuring 12 essential areas that have the biggest impact on how patients view their rehabilitation and recovery, Lifepsychol helps clinicians and next of kin track their loved one’s levels of: